4.8 Article

Metabolic Reprogramming of Stromal Fibroblasts through p62-mTORC1 Signaling Promotes Inflammation and Tumorigenesis

Journal

CANCER CELL
Volume 26, Issue 1, Pages 121-135

Publisher

CELL PRESS
DOI: 10.1016/j.ccr.2014.05.004

Keywords

-

Funding

  1. NIH [R01CA132847, R01CA172025, R01CA134530, 5P30CA030199]
  2. U.S. Department of Defense [W81XWH-13-1-0353, W81XWH-13-1-0354, W81XWH-13-1-0105]

Ask authors/readers for more resources

The tumor microenvironment plays a critical role in cancer progression, but the precise mechanisms by which stromal cells influence the epithelium are poorly understood. Here we show that p62 levels were reduced in the stroma of several tumors and that its loss in the tumor nnicroenvironment or stromal fibroblasts resulted in increased tumorigenesis of epithelial prostate cancer cells. The mechanism involves the regulation of cellular redox through an mTORC1/c-Myc pathway of stromal glucose and amino acid metabolism, resulting in increased stromal IL-6 production, which is required for tumor promotion in the epithelial compartment. Thus, p62 is an anti-inflammatory tumor suppressor that acts through the modulation of metabolism in the tumor stroma.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available